Apple Inc. et al. v. VirnetX Inc.

Case Overview and Background

This dispute involves a long-running and high-stakes patent battle between VirnetX Inc., a publicly traded internet security software and technology company, and Apple Inc., a global technology giant. VirnetX is frequently described as a patent assertion entity (PAE) or patent troll, as its business model is heavily focused on licensing and litigating its patent portfolio. Its portfolio, originally developed by Science Applications International Corporation (SAIC), centers on secure communications technology. Apple is a major operating company that designs, manufactures, and sells consumer electronics, computer software, and online services. The other petitioner, Mangrove Partners Master Fund, is a hedge fund that engages in opportunistic, value-oriented investments. The fund became involved in the validity challenges against VirnetX's patents, a common strategy for investment firms.

The conflict centers on Apple's implementation of secure communication features in its widely used products. VirnetX alleged that Apple's VPN On Demand and FaceTime features infringe its patents. The VPN On Demand feature allows for the automatic creation of a secure Virtual Private Network (VPN) connection, while FaceTime provides encrypted video and audio calls. The core patent at issue in these IPRs is U.S. Patent No. 6,502,135, which discloses a method for creating a secure VPN by transparently intercepting DNS requests and establishing a secure communication link. This technology, and related secure DNS methods described in other VirnetX patents, formed the basis for infringement allegations that resulted in jury verdicts against Apple exceeding hundreds of millions of dollars in the Eastern District of Texas.

The procedural posture of this case is complex, involving parallel proceedings in the U.S. District Court for the Eastern District of Texas and the Patent Trial and Appeal Board (PTAB). While VirnetX secured favorable jury verdicts in Texas, a venue historically known for being friendly to patent holders, Apple and Mangrove Partners challenged the validity of the asserted patents at the PTAB through inter partes review (IPR). This case is notable for the sheer scale of the damages awarded in the district court, the persistence of the litigation over more than a decade, and its illustration of the significant tension between district court outcomes and PTAB validity decisions. The subsequent invalidation of the patent claims by the PTAB, and the affirmation of that decision by the Federal Circuit, ultimately led to the dismissal of the long-standing district court action as moot, wiping out a massive damages award and highlighting the powerful role IPRs play in patent litigation strategy.

Legal Developments and Outcome

The multi-faceted dispute between VirnetX and Apple over U.S. Patent No. 6,502,135 unfolded over more than a decade, marked by parallel proceedings in the U.S. District Court for the Eastern District of Texas and the Patent Trial and Appeal Board (PTAB). Ultimately, the PTAB's invalidation of the patent claims, affirmed on appeal, proved decisive, rendering VirnetX's massive district court judgments unenforceable.

Parallel District Court Litigation

The PTAB proceedings ran concurrently with long-standing and complex litigation in the Eastern District of Texas, primarily in cases number 6:10-cv-00417 (the '417 case) and 6:12-cv-00855 (the '855 case). These cases involved the '135 patent among others and resulted in a series of nine-figure jury verdicts in favor of VirnetX.

• 2010-08-11: VirnetX files the initial lawsuit against Apple (the '417 case), alleging infringement of the '135 patent and others by features like VPN on Demand and FaceTime in Apple's products.
• 2012-11-06: Following the first trial in the '417 case, a jury awards VirnetX over $368 million, finding Apple's products infringed VirnetX's patents. On the same day, VirnetX files a new lawsuit (the '855 case) targeting newer Apple products with similar features.
• 2014-09-16: The U.S. Court of Appeals for the Federal Circuit affirms in-part and vacates in-part the 2012 verdict, sending the case back for a new trial on damages and certain infringement issues.
• 2016-02-04: After a consolidated retrial of the '417 and '855 cases, a jury returns a staggering $625.6 million verdict for VirnetX, finding Apple's infringement was willful.
• 2016-07-29: The district court judge vacates the $625.6 million verdict, citing potential juror confusion from the consolidated trial, and orders the cases to be retried separately.
• 2016-09-30: In the first retrial (of the '417 case), a jury awards VirnetX $302.4 million. This judgment was later increased with interest and costs to approximately $440 million.
• 2018-01-12: The district court denies Apple's motion to stay the '855 case pending the final outcome of the inter partes review (IPR) proceedings at the PTAB. (Case 6:12-cv-00855, E.D. Tex., Docket No. 553)
• 2018-04-11: A jury in the '855 case trial finds Apple's infringement was willful and awards VirnetX $502.6 million.
• 2020-10-30: Following a further remand on damages, another jury in the '855 case awards VirnetX $502.8 million.
• 2021-01-15: The district court affirms the $502.8 million verdict and enters final judgment, also granting VirnetX ongoing royalties.

PTAB Inter Partes Review (IPR2015-01046, IPR2015-01047)

While the district court battles raged on, a separate track to determine the patent's validity was proceeding at the U.S. Patent and Trademark Office.

• 2015-04-10: Mangrove Partners Master Fund, Ltd. and Apple Inc. file petitions for inter partes review against U.S. Patent No. 6,502,135, arguing that the challenged claims were unpatentable based on prior art.
• 2015-10-07: The PTAB institutes the IPR proceedings. In its decision, the Board rejected VirnetX's arguments that the petitions should be denied because Mangrove, a hedge fund, had an improper, profit-driven motive to manipulate VirnetX's stock price. The PTAB stated that the America Invents Act (AIA) was designed to encourage meritorious challenges to patent quality, regardless of the petitioner's specific competitive interest.
• 2016-09-09: The PTAB issues its initial Final Written Decision, finding all challenged claims of the '135 patent unpatentable as either anticipated or obvious over the prior art. (IPR2015-01046, Paper 46).
• 2019-07-31: On appeal, the Federal Circuit vacates the PTAB's decision. The court found that the PTAB had erred in its analysis of a prosecution disclaimer made by VirnetX in a prior reexamination, which affected the proper construction of the patent's claims. The case was remanded for the PTAB to reconsider the prior art in light of the correct claim construction. (VirnetX Inc. v. Mangrove Partners Master Fund, Ltd., 776 F. App'x 693 (Fed. Cir. 2019)).
• 2020-07-14: On remand, the PTAB issues a new Final Written Decision, once again finding the challenged claims of the '135 patent unpatentable under the claim construction mandated by the Federal Circuit. (IPR2015-01046, Paper 70).

Final Disposition: Appeal and Mootness

The PTAB's decision on remand was again appealed, leading to the final resolution of both the IPR and the long-running district court litigation.

• 2023-03-30: The Federal Circuit issues a nonprecedential decision affirming the PTAB's finding on remand that the claims of the '135 patent are unpatentable. The court agreed with the PTAB's analysis that the prior art disclosed the claimed invention, even under the narrower claim scope resulting from the prosecution disclaimer. (VirnetX Inc. v. Mangrove Partners Master Fund, Ltd., Nos. 20-2271, 20-2272 (Fed. Cir. Mar. 30, 2023)).
• 2023-03-31: One day after affirming the PTAB's invalidity decision, the Federal Circuit addresses the pending appeal from the district court's $502.8 million judgment. Citing the now-confirmed unpatentability of the asserted patent claims, the court held that VirnetX no longer had a legally cognizable cause of action. The court vacated the district court's judgment and remanded the case with instructions to dismiss it as moot. (VirnetX Inc. v. Apple Inc., No. 21-1672 (Fed. Cir. Mar. 31, 2023)).
• 2023-09-20: VirnetX files a petition for a writ of certiorari with the U.S. Supreme Court, seeking review of the Federal Circuit's decision that affirmed the PTAB's unpatentability finding. The petition raised questions related to joinder rules under the AIA and the authority of an acting USPTO Director.
• 2024-02-20: The Supreme Court denies VirnetX's certiorari petition, bringing a final close to the dispute over the validity of the '135 patent. This denial cemented the PTAB's invalidation and the mootness of the district court infringement judgments.

Here is the counsel of record for the petitioners, Apple Inc. and Mangrove Partners Master Fund, in the inter partes review proceedings IPR2015-01046 and IPR2015-01047.

Petitioner Counsel: Apple Inc. & Mangrove Partners Master Fund

The petitioners were represented by a team from Wiggin and Dana LLP. Documents from the proceedings and the firm's own publications confirm the key attorneys involved in successfully challenging VirnetX's U.S. Patent No. 6,502,135.

---

Joseph M. Casino

• Role: Lead Counsel (presumed based on practice group leadership)
• Firm: Wiggin and Dana LLP, New York, NY
• Note: As chair of Wiggin and Dana's Intellectual Property Practice Group, Casino is a veteran patent litigator with over 25 years of experience leading teams in high-stakes cases before district courts and the PTAB.

Michael J. Kasdan

• Role: Of Counsel
• Firm: Wiggin and Dana LLP, New York, NY
• Note: A partner in the firm's IP group, Kasdan was publicly credited by the firm as being on the "original team that successfully invalidated the two patents in Inter Partes Review proceedings before the PTAB on behalf of their client, Mangrove Partners."

Abraham Kasdan

• Role: Of Counsel
• Firm: Wiggin and Dana LLP, New York, NY
• Note: His name appears on certificates of service in filings for both IPR2015-01046 and the related IPR2015-01047, directly confirming his role as counsel for the petitioners. He joined Wiggin and Dana with Joseph Casino and Michael Kasdan, with whom he had practiced for many years.

In the inter partes review proceedings IPR2015-01046 and IPR2015-01047 before the Patent Trial and Appeal Board (PTAB), the defendant and patent owner, VirnetX Inc., was represented by counsel from Paul Hastings LLP. Filings from these and related proceedings identify the following attorneys.

Counsel for VirnetX Inc.

• Name: Naveen Modi

  • Role: Lead Counsel
  • Firm: Paul Hastings LLP, Washington, D.C.
  • Noteable Experience: Mr. Modi is the Global Co-Chair of the Intellectual Property practice at Paul Hastings and is widely recognized as a leading attorney for PTAB proceedings, having been involved in over 500 post-grant reviews.

• Name: Joseph E. Palys

  • Role: Counsel
  • Firm: Paul Hastings LLP, Washington, D.C.
  • Noteable Experience: Mr. Palys has represented VirnetX in numerous IPR proceedings and related Federal Circuit appeals, often appearing as arguing counsel.

• Name: Igor Victor Timofeyev

  • Role: Counsel
  • Firm: Paul Hastings LLP, Washington, D.C.
  • Noteable Experience: Mr. Timofeyev was part of the Paul Hastings team representing VirnetX in its appeals of PTAB decisions to the U.S. Court of Appeals for the Federal Circuit.

• Name: Daniel Zeilberger

  • Role: Counsel
  • Firm: Paul Hastings LLP, Washington, D.C.
  • Noteable Experience: Mr. Zeilberger was a member of the legal team representing VirnetX in its patent litigation appeals against Apple Inc.

These attorneys were listed on numerous filings submitted to the PTAB on behalf of VirnetX during the course of the IPRs and the subsequent appeals to the Federal Circuit.